MyAverix Finance
NS · Healthcare
Ambalal Sarabhai Enterprises Ltd (AMBALALSA)
Pharmaceuticals & Biotechnology
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $2.48B, P/E ratio is 22.87, net margin is 40.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AMBALALSA
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) — FAQ
What is Ambalal Sarabhai Enterprises Ltd's market cap?
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) has a reported market cap of $2.48B (data as of 2026-07-11).
What is AMBALALSA's P/E ratio?
The price-to-earnings (P/E) ratio for Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is 22.87 (data as of 2026-07-11).
Does Ambalal Sarabhai Enterprises Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Ambalal Sarabhai Enterprises Ltd (AMBALALSA). Check the MyAverix Finance app for the latest dividend data.
What sector is Ambalal Sarabhai Enterprises Ltd in?
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is AMBALALSA listed on?
AMBALALSA is listed on NS.
What is Ambalal Sarabhai Enterprises Ltd's net margin?
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) reports a net margin of 40.3% (data as of 2026-07-11).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.